Nano-X Imaging (NNOX) Non Operating Investment Income (2021 - 2025)
Nano-X Imaging (NNOX) posted quarterly Non Operating Investment Income of -$1000.0 for Q3 2025, down 101.52% year-on-year from $66000.0 in Q3 2024, and down 125.0% on a QoQ basis from $4000.0 in Q2 2025.
Nano-X Imaging (NNOX) Non Operating Investment Income (2021 - 2025) Analysis & Trends
Nano-X Imaging (NNOX) has reported Non Operating Investment Income for 5 consecutive years, with -$1000.0 the latest figure, recorded in Q3 2025.
- Quarterly Non Operating Investment Income fell 101.52% year-over-year to -$1000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $1000.0 (down 99.67% YoY) and the FY2025 annual result came in at $1000.0, down 99.67% from the prior year.
- Non Operating Investment Income fell to -$1000.0 in Q3 2025 per NNOX's latest filing, from $4000.0 in the prior quarter.
- Over the last five years, Non Operating Investment Income for NNOX reached as high as $485000.0 in Q4 2022 and fell as low as -$1.4 million in Q1 2022.
- A 5-year average of -$88400.0 and a median of -$2000.0 in 2025 frame the typical range for Non Operating Investment Income.
- The largest YoY upside for Non Operating Investment Income was 216.31% in 2022 against a maximum downside of 243.24% in 2022.
- Year by year, Non Operating Investment Income stood at -$417000.0 in 2021, then soared by 216.31% to $485000.0 in 2022, then fell by 29.69% to $341000.0 in 2023, then tumbled by 103.81% to -$13000.0 in 2024, then soared by 92.31% to -$1000.0 in 2025.
- According to Business Quant data, Non Operating Investment Income over the past three periods registered -$1000.0, $4000.0, and -$2000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Nano-X Imaging | 62,810.26 | -44.16 Mn | -2.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | 66,000.00 |
| Sep 30, 2024 | 66,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | 187,000.00 |
| Mar 31, 2024 | 187,000.00 |
| Dec 31, 2023 | 341,000.00 |
| Dec 31, 2023 | 341,000.00 |
| Dec 31, 2022 | 485,000.00 |
| Dec 31, 2022 | 485,000.00 |
| Sep 30, 2022 | -254,000.00 |
| Sep 30, 2022 | -254,000.00 |